Lung cancer deaths among women expected to increase worldwide

How to Make Chips Out of Almost Anything 
August 27, 2018
Woman’s Doctor: Hepatitis C can be cured, doctor says
August 28, 2018
Show all

Lung cancer deaths among women expected to increase worldwide

More women are dying from lung cancer.

Lung cancer death rates for women worldwide are expected to increase over the next 12 years and the problem will be worse in high-income countries than middle-income ones, according to a new study published Wednesday in the Journal of Cancer Research.

Although cancer death rates overall are on a steady decline for women, the study, conducted by researchers in Spain, predicts that lung cancer deaths among women will rise 43 percent globally by 2030, while breast cancer deaths are expected to increase at a much slower rate — just 9 percent in the next decade or so. The study looked at data for 52 countries between 2008 and 2014 from the World Health Organization’s (WHO) Mortality Database.

Lung cancer is the deadliest cancer in the world with 1.69 million deaths in 2015 alone, according to the WHO. But while its incidence in men has been declining after experiencing a sharp epidemic, researchers found, the lung cancer epidemic in women has generally started later.

According to the American Cancer Society, among women, the specific cancers that lead to death most frequently are breast, colorectal, lung, cervix and stomach cancers. Breast cancer mortality rates have fallen thanks to better prevention and management, the study found.

But lung cancer trends in women have been more negative. Although new lung cancer cases over the past 39 years have dropped by 32 percent for men, they have risen 94 percent for women in the U.S., alone, according to the American Lung Association.

Read on: Lung cancer deaths among women expected to increase worldwide: Study – ABC News 

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.